Low concentrations of Wogonin (10–40 μM) with safety and low-toxicities showed the strong potency to increase chemotherapeutic agents induced apoptosis though inactivation of Nrf2 via NF-κB signaling in the resistant cancer cells. This evidence concerns the gene NFKB1 and cancer.